[EN] SULFONAMIDES DERIVATIVES AS URAT1 INHIBITORS<br/>[FR] DÉRIVÉS SULFONAMIDES UTILISÉS EN TANT QU'INHIBITEURS D'URAT1
申请人:PFIZER LTD
公开号:WO2016034971A1
公开(公告)日:2016-03-10
The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a sulfonamide URAT1inhibitor of formula (I), or a pharmaceutically acceptable salt thereof for use as a medicament, wherein R1, X1 and m as defined in the description, and to certain new sulfonamide URAT1 inhibitors. URAT1 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly gout.
The design, synthesis and evaluation of low molecular weight acidic sulfonamides as URAT1 inhibitors for the treatment of gout
作者:Andy Pike、R. Ian Storer、Robert M. Owen、Emma Armstrong、Caroline L. Benn、Magda Bictash、Kathy F. K. Cheung、Kathryn Costelloe、Emmanuel Dardennes、Emma Impey、Philip H. Milliken、Elisabeth Mortimer-Cassen、Hannah J. Pearce
DOI:10.1039/c6md00191b
日期:——
A series of low molecular weight and synthetically facile acidic sulfonamides that are potent and selective URAT1 inhibitors is described.